Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Telemedicine Shown Feasible for Parkinson’s Care

Findings from a one-year clinical trial show individuals in the U.S. with Parkinson’s disease can receive quality care through telemedicine comparable to persons with the disorder receiving the usual care from neurologists alone. . . . → Read More: Telemedicine Shown Feasible for Parkinson’s Care

Trial Testing Engineered Virus as Cancer Treatment

A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers. . . . → Read More: Trial Testing Engineered Virus as Cancer Treatment

Patent Set for Peptide Nerve Damage Treatments

The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4. . . . → Read More: Patent Set for Peptide Nerve Damage Treatments

Peptide Immunotherapy Shown Safe for Type 1 Diabetes

In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes. . . . → Read More: Peptide Immunotherapy Shown Safe for Type 1 Diabetes

Trial Underway Testing New ALS Treatment

Patients in a clinical trial testing a treatment for amyotrophic lateral sclerosis, or ALS, began receiving their first doses administered by the study team. . . . → Read More: Trial Underway Testing New ALS Treatment

Trial to Test Inhaled Insulin, App for Diabetes Mgmt

A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app. . . . → Read More: Trial to Test Inhaled Insulin, App for Diabetes Mgmt

Migraine Treatment Shown Effective in Late Trial

Results of a clinical trial show a single dose of new drug relieved migraine pain among more people with the condition, compared to a placebo. . . . → Read More: Migraine Treatment Shown Effective in Late Trial

FDA Clears Algorithm-Assisted Cancer Diagnosis

The U.S. Food and Drug Administration cleared for marketing a diagnostics system aided by machine learning algorithms to help radiologists detect breast cancer. . . . → Read More: FDA Clears Algorithm-Assisted Cancer Diagnosis

RNA Vaccine for Rabies Found Safe, Generates Antibodies

A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies. . . . → Read More: RNA Vaccine for Rabies Found Safe, Generates Antibodies

Lilly Licensing Autoimmune Therapy in $400M Deal

Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system. . . . → Read More: Lilly Licensing Autoimmune Therapy in $400M Deal